Aspen Pharmacare Holdings Limited

$9.41 0.00%(+$0.00)
TickerSpark Score
60/100
Mixed
80
Valuation
35
Profitability
15
Growth
68
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a APNHY research report →

52-Week Range100% of range
Low
$5.24
Current
$9.41
High
$9.41
Company Overviewwww.aspenpharma.com

About the company

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic agents, analgesics, and hormone replacement medicines under the Arixtra, Diprivan, Fraxiparine, Marcaine, Sustanon, and Xylocaine brands; over-the-counter medicines under the Emla, Maltofer, Ovestin, Solpadeine, and Xylocaine brands; and prescription products for anti-inflammatories, immunosuppressants, hypothyroidism, anti-gout, analgesics, and corticosteroids under the Eltroxin, Imuran, Lipitor, Lyrica, and Zyloric brands.

CEO
Stephen Saad
IPO
2010
Employees
9,262
HQ
Durban, GP, ZA

Price Chart

+39.00% · this period
$9.41$7.33$5.24Jul 02Dec 31Jul 02
Valuation
Market Cap
$4.18B
P/E
-35.08
P/S
1.82
P/B
0.86
EV/EBITDA
53.94
Div Yield
1.34%
Profitability
Gross Margin
41.91%
Op Margin
16.01%
Net Margin
-5.19%
ROE
-2.41%
ROIC
5.32%
Growth & Income
Revenue
$43.36B · -3.00%
Net Income
$-1,083,000,000 · -124.59%
EPS
$-2.44 · -124.62%
Op Income
$1.44B
FCF YoY
-84.93%
Performance & Tape
52W High
$9.41
52W Low
$5.24
50D MA
$8.68
200D MA
$7.14
Beta
0.34
Avg Volume
185

Get TickerSpark's AI analysis on APNHY

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · APNHY

Our APNHY coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on APNHY yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate APNHY report →
Internal Compare

Similar companies

Peers in the same neighborhood.